Democrats want to make insulin a major part of drug-pricing legislation set for a vote this week, but face a Senate rules hurdle, senators said.
Democratic leaders want to reinstate two major provisions of their drug-pricing language, Sen. Jeanne Shaheen (D-N.H.), said Tuesday. One would automatically subject insulin products to government negotiations for lower prices and the other would cap what people pay out of pocket for insulin at $35 per month.
Insulin can cost almost $100 per vial in the US, more than five times the average cost in Canada. Democrats, seeking to retain their narrow congressional majorities in ...
